Industry Overview - The cannabis industry is experiencing significant changes, with innovation being crucial for growth. The current climate and success of companies are closely tied to the performance of marijuana stocks, especially during election years when candidates may propose improvements for the industry [1][2] - There is an ongoing struggle for better laws and regulations, which affects legal operators and small-batch farmers. However, the acceptance of cannabis as a legitimate industry is evolving positively [1] Investment Interest - Increased speculation has led more investors to seek top marijuana stocks, with a growing demand for cannabis products driving companies to enhance profitability [2] Key Companies to Watch - **Aurora Cannabis Inc. (NASDAQ: ACB)**: Engages in the production, distribution, and sale of cannabis and derivatives in Canada and internationally. Recently announced results from its 2024 annual general meeting [4] - **Cronos Group Inc. (NASDAQ: CRON)**: Focuses on the marketing of cannabis products in Canada, Israel, and Germany. Recently launched new products, including live resin vapes and ice water hash prerolls across Canada [6][7] - **Organigram Holdings Inc. (NASDAQ: OGI)**: Involved in the production and sale of cannabis and cannabis-derived products in Canada. Recently closed the second tranche of a private placement investment [8]

The cannabis market is abuzz following former President Donald Trump’s recent comments supporting cannabis legalization in Florida. During a podcast interview, Trump backed the state’s recreational cannabis initiative and emphasized the need for a lawful and regulated framework. This comes as Florida prepares to vote on a ballot initiative in November, which could reshape the cannabis landscape.Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for ...

3 Canadian Marijuana Stocks To Buy In The Stock MarketWhen it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.But things are a bit more diverse for cannabis investing. For most US-based legal operators in the market, man ...

Core Viewpoint - The U.S. Drug Enforcement Administration (DEA) announced a proposal hearing on the reclassification of marijuana to a Schedule III drug, scheduled for December 2, which has led to a negative reaction in cannabis stocks as market participants speculate on the potential impact of the upcoming presidential election on this decision [1] Company Responses - Canopy Growth Corp (NASDAQ:CGC) experienced a significant decline of 10.3%, trading at $5.54, marking its lowest level in six months. The stock has been on a downward trend since failing to maintain the $8.50 level after a rally in late March, although it still shows a year-over-year increase of 41.4% [1] - Cronos Group Inc (NASDAQ:CRON) saw a decrease of 3.5%, trading at $2.22. The stock has been in penny stock territory since November 2021, with the 80-day moving average limiting its price movements since June. Over the past three months, CRON has lost 17.2% [1] - Aurora Cannabis Inc (NASDAQ:ACB) also reacted negatively, down 5.1% to $6.15. The stock is testing support at the 40-day moving average, which was established in mid-July, after a recent rally failed to reach the $7.20 level. Despite this, ACB is still up 28.4% in 2024 [2]

Aurora Cannabis Inc (NASDAQ:ACB) and Lumen Technologies Inc (NYSE:LUMN) are this week's picks for Schaeffer's Cheap Seats: Stocks Under $20 segment. Though in completely different sectors, both stocks have one thing in common -- their soaring price action today. Plus, each were within penny stock territory within the past couple months.At last glance, ACB was up 5.4% at $6.20 after the Canada-based cannabis company's fiscal first-quarter results. The stock has been seeing pressure near $6.30 for roughly the ...

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 68.57%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced earnings of $0.11, delivering a surprise of 161.11%.Over the last four quarters, the company has s ...

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three months ended June 30, 2024 and 2023 (in Canadian Dollars) Table of Contents | Condensed Consolidated Interim Statements of Financial Position | | | | 3 | | --- | --- | --- | --- | --- | | Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) | | | | 4 | | Condensed Consolidated Interim Statements of Changes in Equity | | | | 6 | | Condensed Consolidated Interim Statements o ...

NASDAQ | TSX: ACB Your vote is important no matter how many shares you own. Please vote today. Shareholders with questions or who need assistance voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group (Toll-Free Tel: 1-877-452-7184 / International Tel: 1-416-304-0211 E-mail: [email protected]) EDMONTON, AB, July 30, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medic ...

NASDAQ | TSX: ACB EDMONTON, AB, July 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2025 before the opening of markets that same day. Conference Cal ...

Industry Overview - The marijuana sector is characterized by high volatility, making it challenging for investors to navigate [1][2] - Despite past quick turnarounds, current trends indicate that marijuana stocks have been on the downside, but there is positive speculation about future developments in the industry [2] Key Companies Aurora Cannabis Inc. - Aurora Cannabis Inc. operates in the production, distribution, and sale of cannabis and cannabis derivative products, both in Canada and internationally [4] - The company has received expanded cultivation licenses for a facility in Germany, allowing it to cultivate additional products and cater to the growing German patient base [5] SNDL Inc. - SNDL Inc. is involved in the production, distribution, and sale of cannabis products in Canada, with operations across various segments including Liquor Retail and Cannabis Retail [7] - The company is set to announce its Q2 2024 financial results on August 2, 2024, followed by a conference call [8] Organigram Holdings Inc. - Organigram Holdings Inc. focuses on the production and sale of cannabis and cannabis-derived products in Canada [9] - The company has made a $1 million investment into Phylos to enhance its auto flower and rare cannabinoid portfolio, with plans to receive unique auto-flower seed varietals for testing by September 30, 2024 [9]